Evidence map›Paper›PMID 30360364›Full record

ReviewInternational journal of molecular sciences2018

Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders.

Douglas A Gibson, Ioannis Simitsidellis, Frances Collins, Philippa T K Saunders

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Androgen signalling in the ovaries and endometrium.Molecular human reproduction · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Douglas A GibsonCentre for Inflammation Research, The University of Edinburgh, EH16 4TJ Edinburgh, UK. d.a.gibson@ed.ac.uk.ORCID 0000-0002-9949-1983
Ioannis SimitsidellisCentre for Inflammation Research, The University of Edinburgh, EH16 4TJ Edinburgh, UK. ioannis.simitsidellis@ed.ac.uk.
Frances CollinsCentre for Inflammation Research, The University of Edinburgh, EH16 4TJ Edinburgh, UK. f.collins@ed.ac.uk.
Philippa T K SaundersCentre for Inflammation Research, The University of Edinburgh, EH16 4TJ Edinburgh, UK. p.saunders@ed.ac.uk.
Centre for Inflammation Research · GB

Funding

Medical Research Council MR/N024524/1Medical Research Council MR/P00265X/1
6 · The paper itself

Abstract

Peripheral tissue metabolism of steroids (intracrinology) is now accepted as a key way in which tissues, such as the endometrium, can utilise inactive steroids present in the blood to respond to local physiological demands and 'fine-tune' the activation or inhibition of steroid hormone receptor-dependent processes. Expression of enzymes that play a critical role in the activation and inactivation of bioactive oestrogens (E1, E2) and androgens (A4, T, DHT), as well as expression of steroid hormone receptors, has been detected in endometrial tissues and cells recovered during the menstrual cycle. There is robust evidence that increased expression of aromatase is important for creating a local microenvironment that can support a pregnancy. Measurement of intra-tissue concentrations of steroids using liquid chromatography⁻tandem mass spectrometry has been important in advancing our understanding of a role for androgens in the endometrium, acting both as active ligands for the androgen receptor and as substrates for oestrogen biosynthesis. The emergence of intracrinology, associated with disordered expression of key enzymes such as aromatase, in the aetiology of common women's health disorders such as endometriosis and endometrial cancer has prompted renewed interest in the development of drugs targeting these pathways, opening up new opportunities for targeted therapies and precision medicine.

Indexed as

AndrogensDehydroepiandrosteroneEndometriumEstrogensFemaleHumansTestosteroneUterine DiseasesAndrogensDehydroepiandrosteroneEstrogensTestosteronearomatasedecidualisationdehydroepiandrosterone (DHEA)endometrial cancerendometriosisoestradiolsulfatasetestosterone

Identifiers

PMID30360364
PMCPMC6214123
OpenAlexW2894914503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.